Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
暂无分享,去创建一个
Luba Nalysnyk | Philip Rotella | D. Esser | L. Nalysnyk | P. Rotella | J. Cid-Ruzafa | Javier Cid-Ruzafa | Dirk Esser
[1] A. Woodcock,et al. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. , 1995, Thorax.
[2] W. Travis,et al. Early interstitial lung disease in familial pulmonary fibrosis. , 2007, American journal of respiratory and critical care medicine.
[3] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[4] R. Hubbard,et al. The rising incidence of idiopathic pulmonary fibrosis in the UK , 2011, Thorax.
[5] B. Burrows,et al. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.
[6] Moisés Selman,et al. Idiopathic pulmonary fibrosis , 2011, The Lancet.
[7] N. Sharief,et al. Idiopathic interstitial pneumonitis in children: A national survey in the United Kingdom and Ireland , 2002, Pediatric pulmonology.
[8] S. Kudoh,et al. Occupational and Environmental Factors and Idiopathic Pulmonary Fibrosis in Japan , 2005 .
[9] K P Offord,et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[10] E. Bagiella,et al. Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis: A UNOS/OPTN Database Analysis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] J. Samet,et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. , 2000, American journal of epidemiology.
[12] M. Demedts,et al. REGISTRATION OF INTERSTITIAL LUNG DISEASES BY 20 CENTRES OF RESPIRATORY MEDICINE IN FLANDERS , 2001, Acta clinica Belgica.
[13] M. Humbert,et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome , 2009, European Respiratory Journal.
[14] H Page McAdams,et al. Clinical and pathologic features of familial interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.
[15] H. Collard,et al. Classification and Natural History of the Idiopathic Interstitial Pneumonias Who Is at Risk of Ipf? What Causes Ipf? , 2022 .
[16] V. Kolek. Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia. , 1994, Acta Universitatis Palackianae Olomucensis Facultatis Medicae.
[17] D. Bouros,et al. Epidemiology of interstitial lung diseases in Greece. , 2009, Respiratory medicine.
[18] W. Black,et al. The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.
[19] G. Oster,et al. Incidence and prevalence of idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.
[20] A. Gulsvik,et al. Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. , 2003, Respiratory medicine.
[21] Paul J. Friedman,et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.
[22] S. Nathan,et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. , 2006, Chest.
[23] J. Ancochea,et al. Report on the incidence of interstitial lung diseases in Spain. , 2004, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[24] C. Tinelli,et al. The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report. , 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[25] R. Hubbard,et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK , 2006, Thorax.
[26] Arnold Simanowitz,et al. international consensus statement , 2000 .
[27] B. Burrows,et al. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.
[28] J. Samet,et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. , 2000, American journal of epidemiology.
[29] D. Schroeder,et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. , 2010, Chest.
[30] T. Hartman,et al. Familial idiopathic pulmonary fibrosis: clinical features and outcome. , 2005, Chest.
[31] T. Laitinen,et al. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland , 2002, Thorax.
[32] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[33] V. Poletti,et al. Comparison of registries of interstitial lung diseases in three European countries. , 2001, The European respiratory journal. Supplement.
[34] E. Bagiella,et al. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. , 2011, American journal of respiratory and critical care medicine.
[35] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .
[36] M. Bando,et al. Idiopathic pulmonary fibrosis—results from a Japanese nationwide epidemiological survey using individual clinical records , 2008, Respirology.